MedPath

Difference between effect of Ashwagandha (Withania Somnifera) and Brahmi (Bacopa monnieri Linn) on stress level and quality of sleep in patients experiencing stress.

Phase 3
Conditions
Health Condition 1: F450- Somatization disorder
Registration Number
CTRI/2023/12/060756
Lead Sponsor
Dr Mohnish Gokhale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Body mass index 18–29 kg/m2

2 Healthy as determined by medical history physical examination, and clinical judgment of the investigator under perceived stress with a score of 14–24 on the PSS

3 Cognitively sound as confirmed by the Montreal Cognitive Assessment test

4 Willing and able to provide written informed consent and agreed to attend regular follow-ups

5 Patients with controlled NIDDM & HTN

Exclusion Criteria

1 Pregnant & lactating woman

2 Subjects with an education level below the eighth grade and unable to read

3 Subjects with any severe comorbid medical conditions or any clinically significant systemic disease with significant medication use

4 Subjects with a history of drug dependence alcohol intake or having nicotine or caffeine dependence

5 Night duty people

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath